Why the study?
Heart failure remains a major public health problem with poor prognosis in end-stage disease despite current pharmacological treatments, motivating exploration of gene therapy as a novel approach to repair molecular abnormalities.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Milano et al. (2012) conducted a review in Chronic Heart Failure. Gene therapy was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: